SMS Pharmaceuticals Limited Stock Price Today (NSE: SMSPHARMA)
Fundamental Score
SMS Pharmaceuticals Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
SMS Pharmaceuticals Limited share price today is ₹402.95, down 1.76% on NSE/BSE as of 16 September 2026. SMS Pharmaceuticals Limited (SMSPHARMA) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹3.77K (Cr). The 52-week high for SMSPHARMA share price is ₹482.00 and the 52-week low is ₹242.25. At a P/E ratio of 35.85x, SMSPHARMA is currently trading above its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 14.32% and a debt-to-equity ratio of 0.46.
SMS Pharmaceuticals Limited Share Price Chart — NSE/BSE Historical Performance
SMS Pharmaceuticals Limited share price chart: 9.52% return over the past month. 52-week high ₹482.00, 52-week low ₹242.25.
SMS Pharmaceuticals Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹410.20 | ₹413.35 | ₹393.25 | ₹402.95 | 8.03L (Cr) | |
| ₹477.95 | ₹482.00 | ₹397.50 | ₹410.15 | 43.15L (Cr) | |
| ₹417.85 | ₹469.00 | ₹414.55 | ₹463.45 | 104.02L (Cr) | |
| ₹410.55 | ₹421.00 | ₹407.00 | ₹417.45 | 5.62L (Cr) | |
| ₹405.00 | ₹417.70 | ₹402.05 | ₹407.30 | 5.24L (Cr) | |
| ₹402.70 | ₹409.40 | ₹394.15 | ₹399.15 | 6.35L (Cr) | |
| ₹390.00 | ₹444.00 | ₹387.45 | ₹397.95 | 38.71L (Cr) | |
| ₹374.00 | ₹398.40 | ₹373.00 | ₹392.50 | 4.73L (Cr) | |
| ₹373.05 | ₹376.40 | ₹368.55 | ₹374.15 | 57.59K (Cr) | |
| ₹367.00 | ₹376.00 | ₹362.10 | ₹373.05 | 1.77L (Cr) |
SMS Pharmaceuticals Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹374.20 | ₹482.00 | ₹362.10 | ₹402.95 | +7.68% | |
| ₹375.75 | ₹383.90 | ₹349.25 | ₹371.85 | -1.04% | |
| ₹414.00 | ₹438.30 | ₹365.40 | ₹373.90 | -9.69% | |
| ₹369.25 | ₹428.85 | ₹351.00 | ₹412.55 | +11.73% | |
| ₹406.10 | ₹438.45 | ₹361.70 | ₹369.25 | -9.07% | |
| ₹393.80 | ₹447.80 | ₹370.25 | ₹403.70 | +2.51% | |
| ₹372.00 | ₹433.90 | ₹356.20 | ₹374.85 | +0.77% | |
| ₹314.95 | ₹403.00 | ₹307.80 | ₹385.20 | +22.31% | |
| ₹309.40 | ₹360.00 | ₹293.15 | ₹316.60 | +2.33% | |
| ₹323.55 | ₹334.00 | ₹302.05 | ₹310.40 | -4.06% | |
| ₹283.95 | ₹335.00 | ₹270.10 | ₹319.20 | +12.41% | |
| ₹246.15 | ₹304.98 | ₹245.21 | ₹285.69 | +16.06% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
SMS Pharmaceuticals Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
SMS Pharmaceuticals Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SMSPHARMA across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Excellent ROCE Performance (15.20%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (17.69%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Strong Interest Coverage (6.05x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Healthy Liquidity Position (Current Ratio: 1.71)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Balanced Promoter Holding (68.07%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Risk Factors
3 factors identified
High Price-to-Book Ratio (5.58x)
Observation: Trading at significant premium to book value.
Analysis: High P/B ratios may indicate overvaluation relative to asset base.
Negative Free Cash Flow (₹-104.70 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 3.48%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
SMS Pharmaceuticals Limited vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare SMS Pharmaceuticals Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
SMS Pharmaceuticals LimitedSMS Pharmaceuti...Selected✓ SMSPHARMA • 532815 | 29.3/100 | ₹402.95₹403 | ₹3773.71₹3773.71 | 35.85Average 35.8 Average | 14.32%Average 14.32% Average | 15.20%Good 15.20% Good | 0.46Excellent 0.5 Excellent | 10.30%Good 10.30% Good | 9.51%Good 9.51% Good | 0.10% |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1864.90₹1865 | ₹447445.46₹447445.46 | 37.00Average 37.0 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 56.3/100 | ₹9488.00₹9488 | ₹251432.00₹251432.00 | 86.09Average 86.1 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹4930.00₹4930 | ₹166860.78₹166860.78 | 78.75Average 78.8 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1127.40₹1127 | ₹112514.52₹112514.52 | 25.13Average 25.1 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 40.2/100 | ₹1363.10₹1363 | ₹110118.03₹110118.03 | 32.66Average 32.7 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 34.1/100 | ₹1937.00₹1937 | ₹104646.43₹104646.43 | 95.61Average 95.6 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1698.90₹1699 | ₹97754.71₹97754.71 | 26.55Average 26.5 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 83.4/100 | ₹2100.00₹2100 | ₹96022.50₹96022.50 | 17.35Average 17.4 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 41/100 | ₹1145.00₹1145 | ₹95607.50₹95607.50 | 29.59Average 29.6 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2265.00₹2265 | ₹93544.50₹93544.50 | 45.77Average 45.8 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price447445.46 Cr
- Divi's Laboratories Limited share price251432.00 Cr
- Torrent Pharmaceuticals Limited share price166860.78 Cr
- Zydus Lifesciences Limited share price112514.52 Cr
- Cipla Limited share price110118.03 Cr
SMS Pharmaceuticals Limited PE Ratio History
Historical price-to-earnings ratio for SMSPHARMA — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹8.16 | ₹310.40 | 38x |
| FY 2024 | ₹5.89 | ₹238.85 | 40.6x |
| FY 2022 | ₹7.35 | ₹82.80 | 11.3x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
SMS Pharmaceuticals Limited Dividend History
Annual cash dividends paid by SMSPHARMA — dividend yield 0.10%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹3.39 Cr |
| FY 2024 | ₹2.54 Cr |
| FY 2023 | ₹2.54 Cr |
| FY 2022 | ₹2.54 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
SMS Pharmaceuticals Limited Quarterly Performance
Latest quarterly metrics for SMSPHARMA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
5.57%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
2.04%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
9.51%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
10.30%
Compounded annual net profit growth over 5 years
SMS Pharmaceuticals Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SMSPHARMA — calculated from daily price history
Momentum is strong — price may be stretched. Watch for pullbacks.
Technical indicators are for educational purposes only. Not investment advice.
SMS Pharmaceuticals Limited Financial Statements
Annual income statement, balance sheet and cash flow for SMS Pharmaceuticals Limited (SMSPHARMA) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for SMS Pharmaceuticals Limited
About SMSPHARMA (SMS Pharmaceuticals Limited)
SMS Pharmaceuticals Ltd is a dynamic pharmaceutical company deeply rooted in the development, manufacture, and global distribution of critical active pharmaceutical ingredients (AP...Is) and advanced intermediates. Specializing in a diverse therapeutic spectrum, SMS Pharma addresses pressing health needs worldwide with products spanning anti-retrovirals vital for managing HIV, potent anti-inflammatory agents, and innovative antiviral solutions. Beyond these, their portfolio encompasses essential medicines for managing diabetes, fungal infections, epilepsy, migraines, and cardiovascular ailments. SMS Pharma is dedicated to producing high-quality, affordable solutions that improve patient outcomes and accessibility to crucial medications. Focusing on innovation and comprehensive pharmaceutical solutions, SMS Pharma also plays a key role in contract research, with particular expertise in peptide chemistry. This commitment to research and development underscores their dedication to expanding scientific understanding and creating new therapeutic avenues. By engaging in cutting-edge research, SMS Pharma solidifies its position as a forward-thinking player in the pharmaceutical landscape. Their dedication ensures a continuous pipeline of novel drug candidates and process improvements, benefiting both the company and the global healthcare community. SMS Pharma extends its reach far beyond its domestic borders, actively exporting its products to a broad network of approximately 75 countries. This international presence demonstrates not only the quality and reliability of their products but also their commitment to addressing global healthcare challenges. SMS Pharma's widespread distribution network facilitates access to vital medications for patients across diverse regions, affirming its role as a trusted and dependable supplier within the global pharmaceutical market. SMS Pharmaceuticals Ltd strives to reach more countries with innovative pharmaceutical manufacturing and development.
Company Details
Key Leadership
SMSPHARMA Share Price: Frequently Asked Questions
What is the current share price of SMS Pharmaceuticals Limited?
SMS Pharmaceuticals Limited (SMSPHARMA) trades at ₹402.95 on NSE and BSE. Market cap ₹3.77K (Cr). Educational data only.
What is the P/E ratio of SMS Pharmaceuticals Limited?
SMS Pharmaceuticals Limited has a P/E of 35.85x vs industry average 34.89x.
What is the Bull Run score for SMS Pharmaceuticals Limited?
SMS Pharmaceuticals Limited has a Bull Run score of 29.3/100 based on 25+ financial parameters.
Does SMS Pharmaceuticals Limited pay dividends?
SMS Pharmaceuticals Limited has a dividend yield of 0.10%. Past dividends don't guarantee future payments.
What is the ROE of SMS Pharmaceuticals Limited?
SMS Pharmaceuticals Limited has ROE of 14.32%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of SMS Pharmaceuticals Limited?
SMS Pharmaceuticals Limited has debt-to-equity of 0.46.
Is SMS Pharmaceuticals Limited a good investment?
Bull Run gives SMS Pharmaceuticals Limited a score of 29.3/100. This is not investment advice — consult a SEBI-registered advisor.